| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |